Tag: Dr Vedam Ramprasad
Inside the Groundbreaking Genomics Revolution: Unfolding the rise of MedGenome
Tracking the journey of India’s leading genomics solutions company with a promising product portfolio in diagnostics and research services
BioVoice eMagazine March & April 2024 | Issue 2 | Volume...
Cover story tracks the journey of MedGenome, the India’s leading genomics solutions company. Startup Special features MyHealthcare App; Expert Insights by Dr Kausik Maiti, Parexel India; Ankit Kumar, Skye Air; Dr Sat Kumar Tomer, Satyukt Analytics; and Ritwik Bahuguna, Farlense Group
MedGenome announces leadership transitions: Mahesh Pratapneni new Group CEO & Felix...
Co‐Founder Sam Santhosh steps down as Chairman and Group CEO; will remain on Board of Directors
MedGenome & Emmes launch genomics strategic partnership focused on advancing rare...
The two companies have partnered to support the advancement of public health and biopharmaceutical innovation, aimed at accelerating breakthrough treatments, powered by human genomics, for rare disease patients
Experts develop a new breakthrough genetic risk score for heart disease...
MedGenome Labs has conducted a first-ever study on Indian population that validates a novel ‘CAD-PRS’ (coronary artery disease-genome-wide polygenic risk score) to precisely predict the risk of developing a coronary artery disease/myocardial infarction (MI) using a person’s genetic makeup.....................
MedGenome Labs appoints Dr Vedam Ramprasad as its CEO
A genetic scientist with several peer-reviewed publications to his credit, Dr Ramprasad has been with MedGenome since inception and spearheads operations and strategy for the organization.............